Cargando…
High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
BACKGROUND: To report on the activity of high-dose prolonged-infusion ifosfamide (HDIFX) chemotherapy in a retrospective series of patients affected by myxoid liposarcoma treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. PATIENTS AND METHODS: Patients with an advanced myxoid...
Autores principales: | Colia, Vittoria, Fumagalli, Elena, Provenzano, Salvatore, Bertulli, Rossella, Stacchiotti, Silvia, Morosi, Carlo, Collini, Paola, Gronchi, Alessandro, Casali, Paolo G., Sanfilippo, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602616/ https://www.ncbi.nlm.nih.gov/pubmed/28947876 http://dx.doi.org/10.1155/2017/3739159 |
Ejemplares similares
-
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma
por: Colia, Vittoria, et al.
Publicado: (2017) -
High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014) -
Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor
por: Provenzano, Salvatore, et al.
Publicado: (2017) -
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
por: Katz, Daniela, et al.
Publicado: (2012) -
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
por: Stacchiotti, Silvia, et al.
Publicado: (2012)